Other people who have decided to take legal action have similar stories.Ĭhristina Milisic, a plaintiff in a class action lawsuit in Canada, also developed an uncontrollable gambling habit after she started taking Abilify in 2013 to treat hallucinations and paranoia. Her gambling urges vanished soon after, but by that time, her financial losses exceeded $75,000, according to her complaint.
#Udig developers and itsm professional
It wasn’t until Miley hit rock bottom in February 2015 that she got the professional help she needed and a doctor took her off Abilify. At times, she grew so desperate about the situation, that she considered suicide. Sometimes, she wouldn’t return.Īs Miley’s gambling compulsion grew, she drained her family’s bank accounts, and unbeknownst to her husband, she took out a $50,000 loan to pay off gambling debts. She’d often step away from her son’s basketball games during halftime and head to the casino.
She’d tell her family she needed to work late or do Christmas shopping. But soon, Miley began to skip work and secretly headed to the slots any chance she could.Īs her gambling addiction spiraled out of control, she made up other excuses to gamble. She was getting out of the house more, and she considered her visits to the casino as little more than an excursion, according to an article by STAT reporter Megan Thielking. Within a few weeks of starting the medication, the Minnesota mother of four found herself inexplicably drawn to local casinos.Īt first, she thought of her gambling outings as a good thing. The plaintiffs include people like Denise Miley, who began taking Abilify in the fall of 2014 for depression and anxiety. “Abilify injured Plaintiffs, by causing harmful compulsive behaviors including compulsive gambling, resulting in substantial financial, mental, and physical damages,” according to the plaintiff’s master complaint in the Abilify MDL. The plaintiffs contend they could have made better decisions had they been warned of those risks, and they allege Bristol-Myers Squibb and Otsuka “wrongfully and unjustly profited at the expense of patient safety.” They say the manufacturers knew or should have known the medication could cause gambling addictions and other compulsive behaviors, but they failed to warn the public and doctors about the potential dangers for many years. Men and woman who’ve filed lawsuits against Bristol-Myers Squibb and Otsuka allege Abilify was a defective drug. The drug companies also agreed to settle similar claims pending in state courts in New Jersey, California and other states. As of March 2019, a total of 2,430 cases were pending in the Abilify MDL. In February 2019, lawyers for both sides agreed to a settlement that would resolve the remaining cases under Judge Rodgers. Coordinating cases this way, under what’s known as an MDL, creates an efficient process to handle a large number of similar lawsuits.
District Court for the Northern District of Florida and assigned them to Chief Judge M. Judicial Panel on Multidistrict Litigation transferred most federal Abilify lawsuits to the U.S. The plaintiffs allege the drug is defective, and they could have avoided disastrous consequences had they known about the potential side effects. over allegations that the companies failed to warn patients prior to 2016 that the antipsychotic drug could trigger uncontrollable urges to gamble, shop, eat and have sex. Thousands of people have sued Bristol-Myers Squibb Company and Otsuka Pharmaceuticals Inc. But as use of the drug grew, so did reports of unwanted and serious side effects, including serious impulse control problems. When it first became available in the United States in 2002, Abilify was considered a groundbreaking treatment for schizophrenia.
0 kommentar(er)
